All filters
Slidesets
Acquired Integrase Inhibitor Resistance - State of the Art- Daniel Kuritzkes, MD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Clinical Pharmacology of Integrase Inhibitors - State of the Art- Saye Khoo, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Impact of Integrase Inhibitors on the HIV epidemic in Asia- Matthew Law, BA(Hons), MSc, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Integrase Inhibitors in second line treatment- Hongzhou Lu, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Clinical Case - Emphasis on Integrase Inhibitors challenges in Asian countries- Fujie Zhang, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Optimal use of Integrase Inhibitors in routine clinical practice- Kees Brinkman, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Role of Integrase Inhibitors in the clinical care of HIV infected pregnant women and adolescents- Thanyawee Puthanakit, MD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Clinical Case - InSTIs use in Hong Kong- Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Novel Delivery Systems- Saye Khoo, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
The role of InSTIs in International Treatment Guidelines- Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACP
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
Reduced Drug Regimens- Chien-Ching Hung, MD, PhD
Presented at:
Asia-Pacific HIV Clinical Forum 2018
Slidesets
State of the ART: What’s the same – what’s different – is it clinicially relevant?- Charles Flexner, MD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Managing drug-drug interactions in patients with multiple co-medications- Alice Tseng, B.Sc.Phm., PharmD, FCSHP, AAHIVP
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
State of the ART: What’s the same – what’s different – Is it clinicially relevant?- Eric Arts, PhD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Monitoring and avoiding integrase inhibitor toxicity- Gordon Arbess, MD, CCFP
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Reducing HIV associated inflammation – do the drugs matter?- Darrell Tan, BSc, MD, FRCPC, PhD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Improving care of HIV infected women: What needs to be done?- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Reduced drug regimens – Pros and Cons- Gary Rubin, MD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Novel drug delivery systems: will they have a place in routine HIV clinical care? (Not yet available)- Courtney Fletcher, PharmD
Presented at:
Canadian HIV Clinical Forum 2018
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Slidesets
Eradication of HIV- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018